![Atogepant](https://www.cgrpforum.org/wp-content/uploads/Atogepant.jpg)
Atogepant is an oral CGRP receptor antagonist (gepant) in development for the prevention of migraine. Results of a Phase 2b/3 study and the Phase 3 ADVANCE trial will form the basis of regulatory submissions for atogepant in migraine prevention in adults.
Download slideset »